Summary. The possible existence of gastrin-cells in the pancreas was investigated by a comparative immunehistological and immunoehemical study of antral mucosa and pancreas of man, dog, rabbit, rat and pig. Gastrincells were identified in the antral mucosa of all these species with the indirect immunofluorescence and the immunoperoxidase methods. With the same methods, no gastrin-cells were detected in the pancreas in any of the species studied. With radioimmunoassay, serial dilutions of antral or duodenal extracts yielded curves which were identical to those obtained with synthetic human gastrin, whereas pancreatic or islet extracts did not produce any significant displacement of the 125-Igastrin. Therefore, the presence of gastrin-producing ceils in normal pancreas remains questionable.
The presence in the islets of Langerhans of insulinproducing B-cells and glueagon-producing A-cells is beyond any doubt, but the number as well as the function of other types of islet cells are still controversial. More specifically, a dispute remains whether gastrinelaborating cells exist in normal pancreatic islets. The main arguments in favour of gastrin-cel]s being present are :
1. The ulcerogenic tumours of the Zollinger-Ellison syndrome secrete gastrin [1, 2] and are composed of cells which exhibit the same morphological, tinctorial and cytochemical characteristics as the D (or A1)-eells of pancreatic islets and as the gastrin-producing Gcells of the antral mucosa [3, 4, 5, 6, 7] .
2. With the electron-microscope, cells containing granules of a type similar to the G-cells of antral mueosa have boon described in human islets of Langerhans [3, 8, 9, 10, 11] .
3. Several authors have boon able to localize gastrin in the D (or A1)-colls of pancreatic islets with immunefluorescent methods [12, 13, 14] or to detect gastrin in extracts of pancreatic tissue with radioimmunoassay [13, 15] .
However, none of these arguments has remained undisputed. Many of the eytochemical characteristics of the gastrin-producing G-cells are shared in common with other polypeptide-elaborating endocrine cells (the APUD system of Poarso [16.] ) and are therefore far from specific.
The tinctorial and ultrastructural identity of the cells composing the ulcerogenic islet-tumours with either D (or A1) pancreatic-cells or any other type of islet cells has been denied [13, 14, 17, 19] . With bioassay methods, the demonstration of gastrin in normal mammahan pancreas has consistently failed [1, 20, 21, 22, 23, 24] . Even the immunochemical demonstration of gastrin-eells in the islets has been questioned: in a paper principally devoted to the gastrin-cells of the antral mucosa of man, Creutzfeldt et al. [18] state that they have been unable to demonstrate immunereactive gastrin in human pancreas.
In view of these contradictory opinions, we thought it worthwhile to reinvestigate the presence of gastrin in the pancreas. In this paper we shall report 1 ° the results of a comparative immunohistological study of the antral mucosa and of pancreatic islets in man, rat, dog, rabbit and pig ; 2 ° the results of a radioimmunoassay of gastrin in extracts of the pancreas of these species and in micro-dissected pancreatic islets of man.
Material and Methods

Tissue Preparation
The following tissues have been studied: a) pieces of human pancreatic tissue obtained surgically (7 cases) or within four hours of death (22 cases) ; b) pieces of pancreatic tissue from rats [12] , from dogs [8], from rabbits [7] and from pigs [2] , excised immediately after sacrifice; c) biopsies of human antral mucosa obtained either by oral biopsy tube or in the course of surgery for gastric or duodenal ulcer; d) pieces of antral mucosa of rats, dogs, rabbits and pigs excised immediately after sacrifice.
For the demonstration of either gastrin or insulin with the immunofluorescence technique, the following methods of tissue processing were applied: unfixed or fixed (formalin, acetone, methyl alcohol or carbodiimide [25] ) cryostat sections from fresh tissue, cryostat sections from formalin fixed tissue, paraffin sections from freeze-dried tissue, paraffin sections from formalin or carbodiimide [25] fixed tissue.
For the studies with peroxidase-labelled antibodies against either gastrin or insulin the specimens were fixed in Bonin's fluid and embedded in paraffin.
Immunoassay of gastrin was performed in pancreatic tissue extracts from ten humans, seven dogs, seven rabbits, four rats and two pigs. Samples of pancreatic tissue weighing approximately 100 mg were rapidly frozen in dry ice, weighed and homogenized in 0.15 M MAC1--0.01 M phosphate buffer ptI 7.4 (PBS), with the aid of an ultraturrax homogenizer. Thereafter the suspension was immediately boiled for five minutes and centrifuged at 2000 g for twenty minutes. The supernatant was preserved at --20°C. Other pieces of pancreatic tissue or of antral mucosa were boiled in ten volumes of deionized water for sixty minutes , as prescribed by Greider and Mc Guigan [13] .
Freund's complete adjuvant. Cross immunoreactivity of the (SHG 2--17)-antibodies with choleeystokininpancreozymin (CCK-PZ) (lyophilized highly purified, obtained from GIH-Research Unit, Profs. J.E. Jorpes and V. Mutt, Karolinska Instituter, Stockholm, Sweden) occurred only at CCK-PZ concentrations above 25 mg/ml (Fig. 1) . Furthermore the displacement of lesI was much more gradual with CCK-PZ than with SHG 2--17.
Antiinsulin serum was obtained from guinea-pigs repeatedly injected with solutions of three times recrystallized human insulin (kindly supplied by NOVO Industries), emulsified in complete Freund adjuvant. Two large samples of human pancreatic tissue, obtained within 4 h of death and weighing approximately 20 g, were cut in small pieces and boiled in deionized water, for sixty minutes. Thereafter, the suspension was lyophilizcd and the obtained powder was maintained under vacuum at --20°C. At the time of the radioimmunoassay the powder was diluted in PBS at 10 mg/ml and at 30 mg/ml.
One sample of human pancreatic tissue, obtained during surgery, was rapidly frozen in liquid nitrogen. Sections 20 ~ thick were prepared in a cryostat and maintained in the vacuum at --20°C until microdissection of the islets. The dissection was performed by free-hand under a dissecting microscope in a dry room. The samples were then weighed on a quartzfibre balance. Approximately 1.1 ~g of islet tissue was introduced in each vial. The gastrin-content of the material contained in each of the ten vials was assayed.
Preparation of Antibodies to Gastrin
Synthetic human gastrin I (residues 2--17) (SHG 2--17), obtained from Imperial Chemical Industries, was conjugated to rabbit serum albumin (I~SA) (Miles), by means of carbodiimide, according to the method of Goodfriend et al. [26] . Amino-acid analysis with a Beckman autoanalyzer revealed that 8 molecules of SHG 2--17 were conjugated to one molecule of RSA. Three New Zealand white rabbits were immunized by injecting them four times, at three month intervals, with 2 nag of conjugated SI-IG 2--17, emulsifed in
Staining Procedures
For immunofluorescence microscopy, the indirect method of Coons et al. [27] was used. The sections were incubated for thirty minutes, in a moist chamber, at room temperature, in antigastrin or in antiinsulin serum, diluted 1:10 with phosphate buffered saline, pH 7.4. After washing in PBS, the sections were incubated in either fluorescein-labelled goat antirabbit serum (GAR-FITC, Nordic Immunochemicals) for gastrin demonstration or in fluorescein-labelled goat antiguinea-pig serum (GAGP-FITC, Nordic Immunochemicals) for insulin demonstration.
Peroxidase-labelled antibodies to gastrin or to insulin were prepared according to the method of Nakane and Pierce [28] , slightly modified by Misugi et al. [29] . The peroxidase reaction was performed by the method of Graham and Karnovsky [30] , except that postfixation in osmium tetroxide was omitted.
The following control reactions were applied: rabbit serum against SHG 2--17 incubated for 24 h at 4 ° C with either an excess of SHG 2--17 (50 Fg per ml), rabbit serum albumin (1 mg/ml) or cholecystokinin-pancreozymin (50 Fg per ml), serum from non-immunized rabbits, fluorescein-labelled goat antirabbit serum alone and peroxidase-labelled, non-specific antibodies. Equivalent control reactions were performed for the demonstration of insulin.
Ordinary staining procedures for light microscopy were also used: haematoxylin-eosin, lead haematoxylin [31] , aldehyde-thionin [32] , the ttellerstr6m-ttellman- [33] , Sevier-Munger- [34] , and Grimelius [35] silver impregnation procedures.
Radioimmunoassay of Gastrin
Radioiodination of SHG 2--17 with 125I was performed according to the method of Hunter and Greenwood [36] , slightly modified. The reagents were all diluted in phosphate buffer, 0.5 M, pH 7.2. 2 ~g of SHG 2--17 were dissolved in 25 ~1 of buffer and added to 1 me of ~2aI, followed by adding of 38 ~g of chloramine T in 25 ~1 of buffer, 200 ~g of sodium metabisulrite in 100 ~1 of buffer and 1 mg of potassium iodide in 100 ~1 of buffer. The radioiodination mixture was immediately applied to a Sephadex G-10 (Pharmacia Fine Chemicals) column (1.5 by 30 cm) and cluted at room temperature with 0.1 M potassium phosphate, pH 7.4, in 1 ml fractions. The specific activity measured between 200 and 400 mc per ~g of SHG 2--17. The radioiodinated SHG 2--17 was diluted in 0.15 M NaC1, 0.01 N phosphate buffer pH 7.4, containing 1% ovalbumin (Sigma, grade III) and 0.02~o neomycin (Fradyl-A. Christiaens-Brussels). 50 X of standard dilutions of SI-IG 2--17 or 50 2 of serial dilutions of tissue extracts, were incubated with 300 2 of gastrinantiserum, diluted 1:1500, at 4°C for 24 h. Subsequently 50 A of a solution of 125I-SHG 2--17 was added and the mixture was again incubated for 24 h at 4 ° C. Separation of bound from unbound 125I-SHG 2--17 was obtained with the charcoal method of Herbert et al. [37] , modified by Donald [38] . The unbound fraction was counted in a Packard autogamma-speetrometer. All the assays were performed in triplicate. The lower limit of sensitivity of our assay system, ealeulated from standard curves, is between 5 and 10 pg/ ml.
Results
Immunohistology
Cells showing specific gastrin fluorescence (Figs. 2b, 6a and 7a) or a positive peroxidase reaction (Fig. 3a) were numerous in all sections of formalin-fixed (for immune fluorescence) or Bouin-fixed (for immunoperoxidase technique) and paraffin embedded specimens of antral mucosa of man, dog, rabbit, pig and rat. In the first four species, they were localized in the midportion of the pyloric glands; in rat they were situated in the deeper portion of these glands. Specific gastrin fluorescence was not found in the antral mucosa with any of the other methods of tissue preparation (see material and methods).
The control reactions showed complete abolition of fluorescence and of the peroxidase reaction after blocking of the antibodies with an excess of SHG 2--17. On the other hand, the fluorescence was unaffected by submitting the antibodies to rabbit serum albumin or to choleeystokinin-panereozymin. No fluorescence or peroxidase reactions were obtained after incubation with serum from non-immunized rabbits, fluores~ein-labelled goat antirabbit serum alone, or with peroxidase-labelled, non specific antibodies.
In contradistinction, irrespective of the method of tissue processing, specific gastrin immunofluorescenee or a positive peroxidase reaction was never detected in any of the sections of pancreatic tissue, whether from man (Figs. 4a and 5a) , rat, dog, rabbit or pig. A weak fluorescence was sometimes observed in some islet cells, but this was clearly due to auto-fluorescence of lipofuscin. On the other hand, a specific insulin immunefluorescence (Fig. 4b) and a positive insulin immunoperoxidase reaction (Fig. 5b) were regularly obtained in the islets of all the specimens of pancreatic tissue.
Sections of antral mueosa which were negative for insulin with immunofluorescenee (Fig. 2 a) were retested with antibodies against gastrin. Conversely, sections of pancreatic tissue in which gastrin cells could not be demonstrated (Fig. 4a) were retested with antibodies against insulin. In both cases, the results were positive (Figs. 2b and 4b) .
The G-cells of the antral mucosa reacted positively to lead haematoxylin (Figs. 6a and 6b). They were weakly argyrophilie with the Sevier-Munger technique (Figs. 7 a and 7 b), but did not stain with Grimelius and the Hellman-HellerstrSm techniques. The islet cells which stained positively for insulin, remained unstained with lead haematoxylin, but reacted positively to aldehyde-thionin.
l~adioimmunoassay
A calibration diagram using SHG 2--17 concentrations from 0 to 250 pg per 400 ~l of incubation medium is shown in Fig. 8 . Serial dilutions of antral and of duodenal mucosa yielded curves which did not differ from the standard curves of either SHG 2--17 or SHG 1--17.
On the other hand, serial dilutions of extracts of either fundal mucosa or of pancreatic tissue from man, rat and pig never caused any displacement of 125I-gastrin (Fig. 8) . Neither was such a displacement obtained with samples of pure human islet tissue. A very small displacement of l~SI-gastrin was observed in a few assays of dog and rabbit pancreatic tissue extracts, and in solutions of lyophilized extracts of large sample s of human pancreatic tissue. However in all these cases, the figures calculated were close to the lower level of sensitivity of the assay system.
Discussion
Whereas our observations are in complete agreement with those in the literature concerning the presence of gastrin-secreting cells in the antral mucosal glands [18, 39, 40, 41, 42, 43, 44, 45, 46~ 47] , they are at variance with regard to the pancreas. In this gland, other authors have identified gastrin-eontaining cells with immunohistological methods [12, 13, 14] , as well as by radioiramunoassay of pancreatic ~is~sue e~trac~ [13, 15] . With none of these methods have we been able to demonstrate gastrin in the pancreas of five mammalian species, including man. A similar negative finding has already been reported by Creutzfeldt et al. [18] .
We have no ready explanation to offer for these discrepancies. In the first place methodological differences should be considered. Indeed, Greider and Me Guigan [13] , as well as Vassallo et al. [14] have stated explicitly that gastrin-immunofluoreseence fails to appear in paraffin sections of formalin-fixed pancreatic tissue. However, the same method proves excellent for the demonstration of immunoreactive gastrin-eells in the gastric mucosa. Furthermore, as mentioned in "Material and Methods", we tried numerous other methods of tissue preparation, including fresh-frozen cryostat sections, as recommended by Greider and Mc Guigan [13] and by Vassallo et al. [14] , but they all [25] . These authors have pointed out that the demonstration with fluorescinated antibodies of glueagon-cells in the gastrointestinal tract, is wholly dependent on prior fixation with earbodiimide, whereas in the pancreatic islets, glucagon-eells can be demonstrated with a variety of fixatives and even in unfixed tissues. They contemplate the possibility that differences in behaviour between pancreatic and enteric glucagon may be due to a dissimilarity in their storage or precursor forms. Not less than five forms of gastrin have already been identified in serum and in tissue extracts: G13 (minigastrin), G17 (little gastrin), G 33 (big gastrin), component-I-gastrin, and "big-big" gastrin [47, 48, 49, 50, 51, 52, 53, 54, 54b] . They differ in molecular size and can be separated by gel filtration. In our study, specific gastrin fluorescence also failed to appear in carbodiimide-fixed material, but this does not rule out the possibility that tissue preparation would affect differently the ability of the different storage forms of gastrin to bind gastrin-antibodies in tissue sections.
Even if factors related to tissue preparation should bear a part in the discrepant results obtained with immunohistochemical methods, they would not explain our failure to demonstrate gastrin with radioimmunoassay of pancreatic tissue extracts: Differences in extraction procedures cannot be implicated, because one of the methods used in our study is identical with that used by Greider and Mc Guigan [13] , who identified significant amounts of gastrin in samples of human pancreatic tissue. Neither can this discrepancy be attributed to a lack of sensitivity of our assay system. The lower limit of gastrin concentration which it is able to detect is approximately 3 pg per mg wet weight pancreatic tissue, a figure well below the values of gastrin-content reported by Greider and Me Guigan (42 to 110 fzg/mg) [13] . I t is true that in a few assays of pancreatic tissue extracts from man, dog and rabbit a small displacement of 125I-gastrin was observed in the assay system, but the figures were so close to the lower limit of detection as to he of questionable significance.
Although our study does not entirely rule out the possible presence of gastrin-producing cells in the pancreas of mammals, it suggests that, if present, they must be in such small number as to be of limited physiological significance. Taking into consideration the common embryological origin of all islet cells and perhaps of all polypeptide elaborating cells [16] , the occasional presence of a few gastrin cells in a pancreas would not be surprising. I n this respect, it is notew o r t h y t h a t t I a n s k y et al. [55] were unable to demonstrate gastrin cells with the immunofluoreseenee technique in the pancreas of three of four dogs ; in the fourth, they found a small number of fluorescent cells, but only in the tail of the pancreas. Even less surprising would be the appearance of gastrin-eells in the pancreas under pathological circumstances.
The latest studies on the ultrastructure of the pancreatic islets [56, 57, 58, 59, 60] leave little doubt that cells other than insulin-and glucagon producing cells are present in these islets. In a previous publication [I0], our group has identified two other types of islet cells, which were designated provisionnally as types III and IV. Four types of islet cells have also been admitted by the revised Wiesbaden classification of gut endocrine cells [61] . However, our previous sug- gestion that type III-cells might be equivalent to the gastrin-secreting cells of the antral mucosa is not born out by the present study. Indeed, the ultrastructural characteristics of these cells resemble much more those of D-cells [62] . The function of the latter cells still remains unknown, but the fact that they are present also in the normal fundus mucosa [63, 64] , where no gastrin can be detected, makes it doubtful that they secrete gastrin.
One of the arguments that has been put forward in favour of gastrin-cells being present in the pancreatic islets of man, is the existence of islet cell turnouts which secrete gastrin (Zollinger-Ellison syndrome). While tumours of endocrine glands usually perform some task of their parent tissue, this is not always the case, and several examples have been published recently of islet tumours which, besides insulin or glucagon, seem to manufacture hormoned entirely different from those produced by normal islets [65, 66, 67] . The secretion of gastrin by the uleerogenic tumours of the ZollingerEllison syndiome is beyond doubt [1, 2] . However, the ultrastructural identity of the cells composing these tumours ~dth D or Al-cells of the pancreatic islets has been questioned [11, 14, 18, 19] . Gastrin-secretion may well be a characteristic newly acquired by tumoral islet cells, but in the light of present study, it cannot be concluded that gastrin-cells are regular components oi normal mammalian pancreatic islets.
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